NBL1 antibody
Principal name
NBL1 antibody
Alternative names for NBL1 antibody
DAN, DAND1, Neuroblastoma suppressor of tumorigenicity 1
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of NBL1 antibody
DAN (differential screening-selected gene aberrative in neuroblastoma) was initially identified as a gene whose expression is downregulated in srctransformed rat fibroblasts. DAN has now been shown to be a prototypical member of the DAN family of secreted glycoproteins that are putative BMP antagonists. DAN family members share a cysteinerich domain that is structurally related to the cysteineknot motif found in TGFβ superfamily ligands. There are at least five mouse DAN family members, including DAN, Gremlin/DRM, Cer1 (Cerberusrelated), Dante and PRDC (protein-related to DAN and cerberus). Additional DAN family members include Xenopus Cerberus, chick Caronte, and C. elegans CeCan 1. Murine DAN binds BMP2 in immunoprecipitation experiments and acts as a BMP antagonist in Xenopus animal cap explants. The DAN family of proteins are thought to act as antagonists by binding BMP ligands and preventing their interactions with signaling receptor complexes. Recombinant mouse DAN have been shown to bind BMP4 in a functional ELISA. It is likely the various DAN family members and other TGFβ BMP antagonists including Noggin, Chordin, Follistatin, and TSG can selectively antagonize the activities of different subsets of TGFβ superfamily ligands. These antagonists represent one of the many elaborate regulatory mechanisms that have evolved to control the bioactivities of the TGFβ superfamily ligands.
General readings
Olakowski, M., et al. (2009) Folia Histochem Cytobiol 47(2): 249-55.
Shaikhibrahim, Z., et al. (2011) Int J Mol Med 28(4): 605-11.






Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP32973PU-N | NBL1 (21-32) antibody |
||||||
![]() |
Goat | Aff - Purified | Hu | WB |
0.1 mg /
€380.00
|
||
| OriGene Technologies GmbH | |||||||
OriGene recommends this product for Western blotting. |
|||||||
| TA316493 | NBL1 antibody |
||||||
| Rabbit polyclonal anti-NBL1 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, ICC/IF, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| AM50052PU-N | NBL1 antibody |
||||||
![]() |
Mouse | IgG1 | AT38G8 | Purified | Hu | E, F, ICC/IF, WB |
0.1 ml /
€330.00
|
| OriGene Technologies GmbH | |||||||
| AM50052PU-S | NBL1 antibody |
||||||
![]() |
Mouse | IgG1 | AT38G8 | Purified | Hu | E, F, ICC/IF, WB |
50 µl /
€220.00
|
| OriGene Technologies GmbH | |||||||
| DM3537P | NBL1 antibody |
||||||
![]() |
Rat | IgG2 | 7K12 | Purified | Ms | WB |
0.1 mg /
€460.00
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301954 | NBL1 (transcript variant 2) |
||||
| Recombinant protein of human neuroblastoma, suppression of tumorigenicity 1 (NBL1), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY417336 | NBL1 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR204641L2V | Lenti ORF particles, Nbl1 (GFP-tagged ORF) - Rat neuroblastoma, suppression of tumorigenicity 1 (Nbl1), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR204641L1V | Lenti ORF particles, Nbl1 (Myc-DDK-tagged ORF) - Rat neuroblastoma, suppression of tumorigenicity 1 (Nbl1), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||





+2 additional images

